COVID-19 vaccines versus pediatric hospitalization
Jaime S. Rosa Duque, Daniel Leung, Ka Man Yip, Derek H.L. Lee, Hung‐Kwan So, Wilfred Hing Sang Wong, YL Lau
Abstract
Vaccine effectiveness of BNT162b2 and CoronaVac against COVID-19-associated hospitalization and moderate-to-severe disease due to SARS-CoV-2 Omicron BA.2 is studied from the 1.36 million doses administered to 766,601 of 953,400 children aged 3-11 years and adolescents aged 12-18 years in Hong Kong as of April 2022. These vaccines confer substantial protection.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPediatricsPneumoniaVirologyDiseaseInfectious disease (medical specialty)OutbreakInternal medicineSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies